These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
401 related articles for article (PubMed ID: 23234514)
21. Impact of hematopoietic chimerism at day +14 on engraftment after unrelated donor umbilical cord blood transplantation for hematologic malignancies. Moscardó F; Sanz J; Senent L; Cantero S; de la Rubia J; Montesinos P; Planelles D; Lorenzo I; Cervera J; Palau J; Sanz MA; Sanz GF Haematologica; 2009 Jun; 94(6):827-32. PubMed ID: 19483157 [TBL] [Abstract][Full Text] [Related]
22. Ex vivo expansion of umbilical cord blood stem cells using different combinations of cytokines and stromal cells. Madkaikar M; Ghosh K; Gupta M; Swaminathan S; Mohanty D Acta Haematol; 2007; 118(3):153-9. PubMed ID: 17890847 [TBL] [Abstract][Full Text] [Related]
24. CD34+ stem cell augmentation of elutriated allogeneic bone marrow grafts: results of a phase II clinical trial of engraftment and graft-versus-host disease prophylaxis in high-risk hematologic malignancies. O'Donnell PV; Jones RJ; Vogelsang GB; Seber A; Ambinder RF; Flinn I; Miller C; Marcellus DC; Griffin C; Abrams R; Braine HG; Grever M; Hess AD; Piantadosi S; Noga SJ Bone Marrow Transplant; 1998 Nov; 22(10):947-55. PubMed ID: 9849691 [TBL] [Abstract][Full Text] [Related]
25. Cotransplantation of ex vivo expanded and unexpanded cord blood units in immunodeficient mice using insulin growth factor binding protein-2-augmented mesenchymal cell cocultures. Ong LM; Fan X; Chu PP; Gay FP; Bari S; Ang JM; Li Z; Chen J; Lim SK; Bunte RM; Hwang WY Biol Blood Marrow Transplant; 2012 May; 18(5):674-82. PubMed ID: 22240732 [TBL] [Abstract][Full Text] [Related]
26. Pre-engraftment syndrome after unrelated donor umbilical cord blood transplantation in patients with hematologic malignancies. Wang X; Liu H; Li L; Geng L; Ding K; Liu X; Tong J; Zhu W; Sun Z Eur J Haematol; 2012 Jan; 88(1):39-45. PubMed ID: 21933279 [TBL] [Abstract][Full Text] [Related]
27. Ex vivo expanded cord blood cells provide rapid engraftment in fetal sheep but lack long-term engrafting potential. McNiece IK; Almeida-Porada G; Shpall EJ; Zanjani E Exp Hematol; 2002 Jun; 30(6):612-6. PubMed ID: 12063029 [TBL] [Abstract][Full Text] [Related]
28. Mesenchymal stromal cell supported umbilical cord blood ex vivo expansion enhances regulatory T cells and reduces graft versus host disease. Fan X; Gay FP; Ong SY; Ang JM; Chu PP; Bari S; Lim TK; Hwang WY Cytotherapy; 2013 May; 15(5):610-9. PubMed ID: 23419678 [TBL] [Abstract][Full Text] [Related]
29. Augmentation of umbilical cord blood (UCB) transplantation with ex vivo-expanded UCB cells: results of a phase 1 trial using the AastromReplicell System. Jaroscak J; Goltry K; Smith A; Waters-Pick B; Martin PL; Driscoll TA; Howrey R; Chao N; Douville J; Burhop S; Fu P; Kurtzberg J Blood; 2003 Jun; 101(12):5061-7. PubMed ID: 12595310 [TBL] [Abstract][Full Text] [Related]
30. Platelet engraftment in patients with hematologic malignancies following unmanipulated haploidentical blood and marrow transplantation: effects of CD34+ cell dose and disease status. Chang YJ; Xu LP; Liu DH; Liu KY; Han W; Chen YH; Yu-Wang ; Chen H; Wang JZ; Zhang XH; Zhao XY; Huang XJ Biol Blood Marrow Transplant; 2009 May; 15(5):632-8. PubMed ID: 19361756 [TBL] [Abstract][Full Text] [Related]
31. Influence of human leucocyte antigen disparity and graft lymphocytes on allogeneic engraftment and survival after umbilical cord blood transplant in adults. van Heeckeren WJ; Fanning LR; Meyerson HJ; Fu P; Lazarus HM; Cooper BW; Tse WW; Kindwall-Keller TL; Jaroscak J; Finney MR; Fox RM; Solchaga L; Forster M; Creger RJ; Laughlin MJ Br J Haematol; 2007 Nov; 139(3):464-74. PubMed ID: 17910637 [TBL] [Abstract][Full Text] [Related]
32. Association between Nondominant Unit Total Nucleated Cell Dose and Engraftment in Myeloablative Double-Unit Cord Blood Transplantation. Purtill D; Stevens CE; Lubin M; Ponce D; Hanash A; Giralt S; Scaradavou A; Young JW; Barker JN Biol Blood Marrow Transplant; 2015 Nov; 21(11):1981-4. PubMed ID: 26211983 [TBL] [Abstract][Full Text] [Related]
33. Cotransplantation of umbilical cord-derived mesenchymal stem cells promote hematopoietic engraftment in cord blood transplantation: a pilot study. Wu KH; Sheu JN; Wu HP; Tsai C; Sieber M; Peng CT; Chao YH Transplantation; 2013 Mar; 95(5):773-7. PubMed ID: 23274973 [TBL] [Abstract][Full Text] [Related]
37. Phase II study of intrabone single unit cord blood transplantation for hematological malignancies. Murata M; Maeda Y; Masuko M; Onishi Y; Endo T; Terakura S; Ishikawa Y; Iriyama C; Ushijima Y; Goto T; Fujii N; Tanimoto M; Kobayashi H; Shibasaki Y; Fukuhara N; Inamoto Y; Suzuki R; Kodera Y; Matsushita T; Kiyoi H; Naoe T; Nishida T Cancer Sci; 2017 Aug; 108(8):1634-1639. PubMed ID: 28582607 [TBL] [Abstract][Full Text] [Related]
38. A prospective investigation of cell dose in single-unit umbilical cord blood transplantation for adults with high-risk hematologic malignancies. Sobol U; Go A; Kliethermes S; Bufalino S; Rodriguez T; Smith S; Parthasarathy M; Stiff P Bone Marrow Transplant; 2015 Dec; 50(12):1519-25. PubMed ID: 26367229 [TBL] [Abstract][Full Text] [Related]
39. [Clinical effect of umbilical cord blood transplantation in 37 pediatric patients with hematologic malignancies: a single-center experience]. Luan Z; Tang XF; Wu NH; Xu SX; Zhang B; Wang K; Du H Zhongguo Dang Dai Er Ke Za Zhi; 2014 Jul; 16(7):714-9. PubMed ID: 25008879 [TBL] [Abstract][Full Text] [Related]